trending Market Intelligence /marketintelligence/en/news-insights/trending/qlkxenx5z_hqufal-r616a2 content esgSubNav
In This List

Novartis unit closes subsequent tender offer for Advanced Accelerator

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Novartis unit closes subsequent tender offer for Advanced Accelerator

Novartis AG's unit Novartis Groupe France SA completed the subsequent offering period of the tender offer to purchase all of the outstanding shares of Advanced Accelerator Applications SA.

Advanced Accelerator's ordinary shares and American depositary shares were priced at $41 and $82 each, respectively.

The subsequent offering period started Jan. 22 and expired Jan. 31.

As of the expiration of the subsequent offering period, 95,127,753 ordinary shares were validly tendered during the initial and subsequent offering period taken together, representing about 98.7% of all outstanding ordinary shares.

The company's unit accepted for payment and has promptly paid, or will promptly pay, for all ordinary shares and ADS validly tendered during the subsequent offering period.

Bank of New York Mellon and Banque Transatlantique SA acted as tender agents for the offer.